Note 14 - Restructuring Costs
|3 Months Ended|
Mar. 31, 2020
|Notes to Financial Statements|
|Restructuring and Related Activities Disclosure [Text Block]||
January 2019,the Company implemented a strategic organizational realignment plan to reduce operating expenses and prepare the Company for expanded indications for its CMRF technology platform for improved sexual function and stress urinary incontinence in women. The restructuring included a reduction in headcount of approximately
40full-time employees. The total restructuring costs were approximately
$742,000and have been recorded in operating expenses in the condensed consolidated statements of operations. The restructuring contributed to a reduction in total operating expenses in the
2019as planned and resulted in additional operating cost savings throughout the remainder of this year.
The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef